V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009337 | 260012227 | 1.77 | 109.9 | Palliative (P) | 2016-04-12 | 2016-05-09 | Rituximab | N | N | 260029679 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009338 | 260012227 | 1.66 | 89.1 | Curative (C) | 2014-08-09 | 2015-04-28 | Chlorambucil | N | N | 260029679 | CISPLATIN + RT |
| 260009339 | 260006061 | 1.72 | 62 | Adjuvant (A) | 2015-03-19 | 2015-07-03 | CHOP | N | N | 260029682 | CISPLATIN + RT |
| 260009340 | 260006062 | 1.55 | 48 | null | null | 2017-01-31 | CAPECITABINE + OXALIPLATIN | null | null | 260029686 | R-EPOCH |
| 260009341 | 260006062 | 0 | 79.5 | Curative (C) | 2017-06-25 | 2017-07-16 | Rituximab | N | N | 260029686 | RITUXIMAB |
| 260009342 | 260006062 | 1.78 | 73.5 | Curative (C) | null | 2012-10-20 | Bendamustine +/- Prednisolone | null | null | 260029686 | BENDAMUSTINE |
| 260009343 | 260006062 | 1.84 | 109 | Curative (C) | 2015-07-16 | 2015-07-16 | CISPLATIN + ETOPOSIDE | 02 | null | 260029686 | CISPLATIN + ETOPOSIDE |
| 260009344 | 260006063 | 1.75 | 66 | Curative (C) | null | 2016-08-09 | INTERFERON | null | null | 260029691 | DOXORUBICIN + IFOSFAMIDE |
| 260009345 | 260006064 | 0 | 99 | null | 2016-12-22 | 2016-12-23 | Rituximab | N | N | 260029692 | PACIFICO TRIAL |
| 260009346 | 260006064 | null | 85.4 | null | 2014-12-28 | 2015-01-06 | Rituximab | N | N | 260029692 | RITUXIMAB |
| 260009347 | 260006065 | null | 48.2 | Curative (C) | null | 2013-08-01 | Rituximab | null | null | 260029695 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 260009348 | 260006065 | 1.52 | 69.8 | null | 2017-08-29 | 2017-09-17 | CHLVPP/EVA | N | null | 260029695 | RITUXIMAB |
| 260009349 | 260006066 | 1.79 | 57.2 | Curative (C) | 2014-10-10 | 2014-10-10 | Bendamustine +/- Prednisolone | N | N | 260029699 | RITUXIMAB |
| 260009350 | 260006067 | null | 96.6 | Curative (C) | 2016-01-26 | 2016-07-26 | Bortezomib (weekly) | N | N | 260029700 | RITUXIMAB |
| 260009351 | 260006067 | null | 92 | Curative (C) | 2014-07-17 | 2014-08-20 | CHLORAMBUCIL + OBINUTUZUMAB | 99 | null | 260029700 | EP |
| 260009352 | 260006068 | null | 87.5 | Palliative (P) | 2014-05-16 | 2014-05-16 | Sunitinib | null | null | 260029703 | TRIAL |
| 260009353 | 260012232 | 1.89 | 73.7 | Curative (C) | 2017-08-18 | 2017-08-19 | Rituximab | 1 | null | 260029704 | RITUXIMAB |
| 260009354 | 260006069 | 1.6 | null | Disease modification (D) | 2016-05-15 | 2016-05-15 | Rituximab | 2 | N | 260029705 | REMODL TRIAL |
| 260009355 | 260012233 | null | 70 | null | 2014-09-18 | 2014-09-18 | Rituximab (Maintenance) | 2 | null | 260029706 | DHAP - R |
| 260009356 | 260006070 | 1.64 | 76 | Curative (C) | 2015-09-25 | 2015-10-12 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029707 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009357 | 260012234 | 1.74 | 73.2 | Curative (C) | 2015-03-02 | 2015-03-09 | ETOPOSIDE | N | N | 260029709 | CARBOPLATIN + ETOPOSIDE |
| 260009358 | 260012234 | 0 | 76 | null | 2014-06-29 | 2017-05-29 | EP | 02 | N | 260029709 | CARBOPLATIN + ETOPOSIDE |
| 260009359 | 260006071 | null | null | null | null | 2014-02-25 | Cisplatin + Etoposide (3 day) | N | N | 260029712 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009360 | 260012235 | null | 90 | null | 2015-04-23 | 2015-04-23 | Vemurafenib | 1 | null | 260029713 | DOCETAXEL |
| 260009361 | 260012235 | 1.65 | 57.7 | Curative (C) | 2017-07-31 | 2017-08-04 | ETOPOSIDE + RITUXIMAB | N | N | 260029713 | RITUXIMAB |
| 260009362 | 260006072 | null | null | Curative (C) | 2017-10-07 | 2017-10-13 | Rituximab | 2 | N | 260029716 | PACLITAXEL |
| 260009363 | 260006072 | null | null | Curative (C) | 2016-02-21 | 2016-03-18 | Rituximab | N | N | 260029716 | CISPLATIN + VINORELBINE |
| 260009364 | 260006072 | 1.64 | null | Disease modification (D) | 2013-05-21 | 2013-05-24 | CETUXIMAB | N | N | 260029716 | CHOP |
| 260009365 | 260006072 | 1.82 | 83.6 | Curative (C) | 2016-06-24 | 2016-06-24 | ETOPOSIDE | 2 | N | 260029716 | POUT TRIAL |
| 260009366 | 260006073 | 1.69 | 45.3 | Palliative (P) | 2017-12-07 | 2017-12-12 | FEC 60 or 75 | N | N | 260029726 | RITUXIMAB |
| 260009367 | 260006073 | 1.71 | 75 | Palliative (P) | 2017-03-22 | 2017-03-23 | Cisplatin + Etoposide (3 day) | 01 | null | 260029726 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009368 | 260006073 | 1.59 | 67.7 | Curative (C) | 2014-12-08 | 2016-01-11 | Carboplatin + Etoposide IV 3 day | N | N | 260029726 | CISPLATIN + ETOPOSIDE |
| 260009369 | 260006073 | 1.75 | 75 | Palliative (P) | null | 2013-05-26 | CISPLATIN + ETOPOSIDE | N | N | 260029726 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009370 | 260018386 | null | null | Curative (C) | 2014-02-19 | 2014-03-02 | Carboplatin + Etoposide IV 3 day | 99 | N | 260029733 | CHOP |
| 260009371 | 260006074 | null | null | Adjuvant (A) | 2014-11-05 | 2014-11-09 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260029735 | RITUXIMAB |
| 260009372 | 260006074 | 1.68 | 64.6 | Curative (C) | 2017-07-27 | 2017-08-08 | EP 1 2 or 3 day | N | N | 260029735 | EP |
| 260009373 | 260006074 | 1.67 | 72.3 | null | 2016-01-05 | 2016-01-12 | CISPLATIN + ETOPOSIDE | 02 | null | 260029735 | CEB |
| 260009374 | 260017444 | 1.68 | 93 | Disease modification (D) | 2013-07-30 | 2013-08-02 | Rituximab | Y | N | 260029738 | GDP |
| 260009375 | 260006075 | 1.75 | 57.4 | Curative (C) | 2014-08-02 | 2014-08-02 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260029740 | CISPLATIN + ETOPOSIDE |
| 260009376 | 260006075 | 1.55 | 62 | Palliative (P) | null | 2016-10-13 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 260029740 | RITUXIMAB |
| 260009377 | 260006076 | 1.8 | 103 | Disease modification (D) | 2013-10-30 | 2013-11-05 | BOP | N | N | 260029745 | CYTARABINE HD + METHOTREXATE HD |
| 260009378 | 260012240 | null | null | Curative (C) | 2013-03-13 | 2013-03-14 | Trial Unspecified | N | N | 260029746 | CISPLATIN + ETOPOSIDE |
| 260009379 | 260012240 | 1.67 | 119.2 | Curative (C) | 2015-02-20 | 2015-02-21 | BLEOMYCIN | 02 | N | 260029746 | ETOPOSIDE |
| 260009380 | 260006077 | 1.8 | null | Curative (C) | 2014-02-11 | 2014-10-07 | EP | N | N | 260029749 | CISPLATIN + ETOPOSIDE |
| 260009381 | 260006077 | 1.68 | null | Curative (C) | 2016-06-29 | 2016-06-29 | GEMCARBO | 02 | N | 260029749 | CISPLATIN + RT |
| 260009382 | 260006077 | 1.78 | 63 | Curative (C) | 2013-02-12 | 2013-02-12 | Carboplatin + Etoposide IV 3 day | N | N | 260029749 | CISPLATIN + ETOPOSIDE |
| 260009383 | 260017445 | 1.79 | null | Adjuvant (A) | 2018-02-13 | 2018-02-27 | ABVD | Y | N | 260029753 | CARBOPLATIN + ETOPOSIDE |
| 260009384 | 260006078 | 1.67 | 70 | Palliative (P) | null | 2018-06-05 | Rituximab | null | N | 260029754 | FEC |
| 260009385 | 260006078 | 1.54 | 74 | Curative (C) | 2015-02-06 | 2015-02-08 | ETOPOSIDE + RITUXIMAB | N | N | 260029754 | RITUXIMAB |
| 260009386 | 260006079 | 1.74 | 116 | Disease modification (D) | 2014-04-25 | 2015-04-28 | EP | N | N | 260029757 | CISPLATIN + ETOPOSIDE |